The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Human Papillomavirus 16 E6 Oncoprotein Interferences with Insulin Signaling Pathway by Binding to Tuberin
Abstract
Tuberous sclerosis complex (TSC) is a genetic disorder caused by mutations in either TSC1 or TSC2 tumor suppressor gene. TSC1 and TSC2 products, Harmatin and Tuberin, form the functional complex to serve as the negative regulator for insulin-induced phosphorylation of S6 kinase and elF4E-binding protein 1. High-risk human papillomavirus (HPV) infection is the necessary cause for cervical cancer. E6 oncoprotein encoded by HPV plays a pivotal role in carcinogenesis by interference with the host intracellular protein functions. In this study, we show that HPV16 E6 interacts with tumor suppressor gene TSC2 product, Tuberin, and results in the phosphorylation of S6 kinase and S6 even in the absence of insulin. The overexpression of Tuberin overcomes the effect of E6 on S6 kinase phosphorylation. Binding with HPV16 E6 causes the proteasome-mediated degradation of Tuberin. A DILG motif and an ELVG motif located in the carboxyl-terminal of Tuberin are required for E6 binding. In addition, the Tuberin interaction region in E6 has been mapped in the amino-terminal portion of HPV16 E6, which is different from the binding domain with p53. These results provide a possible link between E6-induced oncogenesis and the insulin-stimulated cell proliferation signaling pathway.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The mammalian target of the rapamycin (mTOR) kinase, a downstream target of AKT, has been demonstrated to be activated by E6 via E6/E6AP-mediated degradation of the mTOR inhibitor tuberous sclerosis complex 2 (TSC2) [230,231]”
From The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis (2021) · cites this paper as [230]
Citations
Cites
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
Inoki, K., Li, Y., Xu, T., & Guan, K.-L. (2003) · Genes & Development · doi:10.1101/gad.1110003 · Cited by 1,911
Self-citationTee, A. R., Fingar, D. C., Manning, B. D., Kwiatkowski, D. J., Cantley, L. C., & Blenis, J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202476899 · Cited by 827
Ribosomal S6 Kinase Signaling and the Control of Translation
Dufner, A., & Thomas, G. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4683 · Cited by 676
Castro, A. F., Rebhun, J. F., Clark, G. J., & Quilliam, L. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300226200 · Cited by 381
Research works printed but not linked: 54
- zur Hausen, 1996, Biochim. Biophys. Acta, 1288, F55
- Bosch, 2002, J. Clin. Pathol., 55, 244, 10.1136/jcp.55.4.244 · DOI
- Hawley-Nelson, 1989, EMBO J., 8, 3905, 10.1002/j.1460-2075.1989.tb08570.x · DOI · Paper page
- Song, 1999, J. Virol., 73, 5887, 10.1128/JVI.73.7.5887-5893.1999 · DOI
- Schwarz, 1985, Nature, 341, 111, 10.1038/314111a0 · DOI
- Werness, 1990, Science, 248, 76, 10.1126/science.2157286 · DOI · Paper page
- Liu, 1999, J. Virol., 73, 7297, 10.1128/JVI.73.9.7297-7307.1999 · DOI · Paper page
- Nakagawa, 2000, Mol. Cell. Biol., 20, 8244, 10.1128/MCB.20.21.8244-8253.2000 · DOI · Paper page
- Mantovani, 2001, Oncogene, 20, 7874, 10.1038/sj.onc.1204869 · DOI
- Patel, 1999, EMBO J., 18, 5061, 10.1093/emboj/18.18.5061 · DOI · Paper page
- Zimmermann, 1999, J. Virol., 73, 6209, 10.1128/JVI.73.8.6209-6219.1999 · DOI · Paper page
- Kuhne, 1998, J. Biol. Chem., 273, 34302, 10.1074/jbc.273.51.34302 · DOI
- Kukimoto, 1998, Biochem. Biophys. Res. Commun., 249, 258, 10.1006/bbrc.1998.9066 · DOI
- Ronco, 1998, Genes Dev., 12, 2061, 10.1101/gad.12.13.2061 · DOI · Paper page
- Gao, 1999, Mol. Cell. Biol., 19, 733, 10.1128/MCB.19.1.733 · DOI
- Chromosome, 1993, Cell, 75, 1305, 10.1016/0092-8674(93)90618-Z · DOI · Paper page
- van Slegtenhorst, 1997, Science, 277, 805, 10.1126/science.277.5327.805 · DOI · Paper page
- Green, 1994, Nat. Genet., 6, 193, 10.1038/ng0294-193 · DOI
- Momose, 2002, Hum. Mol. Genet., 11, 2997, 10.1093/hmg/11.24.2997 · DOI
- Kobayashi, 2001, Proc. Natl. Acad. Sci. U. S. A., 98, 8762, 10.1073/pnas.151033798 · DOI
- Tapon, 2001, Cell, 105, 345, 10.1016/S0092-8674(01)00332-4 · DOI
- van Slegtenhorst, 1998, Hum. Mol. Genet., 7, 1053, 10.1093/hmg/7.6.1053 · DOI · Paper page
- Hengstschlager, 2001, Mutat. Res., 488, 233, 10.1016/S1383-5742(01)00058-8 · DOI
- McManus, 2002, Nat. Cell Biol., 4, E214, 10.1038/ncb0902-e214 · DOI
- Potter, 2002, Nat. Cell Biol., 4, 658, 10.1038/ncb840 · DOI · Paper page
- Gao, 2001, Genes Dev., 15, 1383, 10.1101/gad.901101 · DOI
- Dan, 2002, J. Biol. Chem., 277, 35364, 10.1074/jbc.M205838200 · DOI
- Inoki, 2002, Nat. Cell Biol., 4, 648, 10.1038/ncb839 · DOI · Paper page
- Saucedo, 2003, Nat. Cell Biol., 6, 566, 10.1038/ncb996 · DOI
- Zhang, 2003, Nat. Cell Biol., 6, 578, 10.1038/ncb999 · DOI
- Kwaitkowski, 2002, Hum. Mol. Genet., 11, 525, 10.1093/hmg/11.5.525 · DOI
- Potter, 2001, Cell, 105, 1383, 10.1016/S0092-8674(01)00333-6 · DOI
- Deng, 1989, Cancer Res., 47, 3195
- Aicher, 2001, J. Biol. Chem., 276, 21017, 10.1074/jbc.C100136200 · DOI
- Gao, 2002, Nat. Cell Biol., 4, 699, 10.1038/ncb847 · DOI
- Thomas, 2002, Oncogene, 21, 5088, 10.1038/sj.onc.1205668 · DOI
- Wu, 2000, Proc. Natl. Acad. Sci. U. S. A., 97, 4233, 10.1073/pnas.97.8.4233 · DOI
- Gardiol, 1999, Oncogene, 18, 5487, 10.1038/sj.onc.1202920 · DOI · Paper page
- Glaunsinger, 2000, Oncogene, 19, 5270, 10.1038/sj.onc.1203906 · DOI · Paper page
- Scheffner, 1990, Cell, 63, 1129, 10.1016/0092-8674(90)90409-8 · DOI · Paper page
- Thomas, 1996, Oncogene, 13, 471
- Elston, 1998, J. Gen. Virol., 79, 371, 10.1099/0022-1317-79-2-371 · DOI
- Manning, 2003, Trends Biochem. Sci., 28, 573, 10.1016/j.tibs.2003.09.003 · DOI · Paper page
- Krymskaya, 2003, Cell Signal., 15, 729, 10.1016/S0898-6568(03)00040-8 · DOI · Paper page
- Li, 2004, Trends Biochem. Sci., 29, 32, 10.1016/j.tibs.2003.11.007 · DOI
- Stocker, 2003, Nat. Cell Biol., 5, 559, 10.1038/ncb995 · DOI
- Garami, 2003, Mol. Cell, 11, 1457, 10.1016/S1097-2765(03)00220-X · DOI · Paper page
- Tee, 2003, Curr. Biol., 13, 1259, 10.1016/S0960-9822(03)00506-2 · DOI · Paper page
- Jones, 1997, Genes Dev., 11, 2101, 10.1101/gad.11.16.2101 · DOI · Paper page
- Sherman, 1996, J. Virol., 70, 3269, 10.1128/jvi.70.5.3269-3279.1996 · DOI
- Thomas, 2001, Oncogene, 20, 5431, 10.1038/sj.onc.1204719 · DOI
- Filippova, 2002, J. Biol. Chem., 277, 21730, 10.1074/jbc.M200113200 · DOI
- Chen, 1995, Science, 269, 529, 10.1126/science.7624774 · DOI · Paper page
- Thomas, 1999, Oncogene, 18, 7690, 10.1038/sj.onc.1202953 · DOI
Cited by
Narisawa‐Saito, M., & Kiyono, T. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00546.x · Cited by 528
Molinolo, A. A., Hewitt, S. M., Amornphimoltham, P., Keelawat, S., Rangdaeng, S., Meneses García, A., Raimondi, A. R., Jufe, R., Itoiz, M., Gao, Y., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1041 · Cited by 243
TSC1 Stabilizes TSC2 by Inhibiting the Interaction between TSC2 and the HERC1 Ubiquitin Ligase
Chong-Kopera, H., Inoki, K., Li, Y., Zhu, T., Garcia-Gonzalo, F. R., Rosa, J. L., & Guan, K.-L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c500451200 · Cited by 234
Self-citationMoorman, N. J., Cristea, I. M., Terhune, S. S., Rout, M. P., Chait, B. T., & Shenk, T. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.03.002 · Cited by 194
Basukala, O., & Banks, L. (2021) · Viruses · doi:10.3390/v13101892 · Cited by 137
Pathogenetic mechanisms of focal cortical dysplasia
Marin‐Valencia, I., Guerrini, R., & Gleeson, J. G. (2014) · Epilepsia · doi:10.1111/epi.12650 · Cited by 100
Terhune, S. S., Moorman, N. J., Cristea, I. M., Savaryn, J. P., Cuevas-Bennett, C., Rout, M. P., Chait, B. T., & Shenk, T. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000965 · Cited by 70
Metadata
- Authors
- Lu, Z., Hu, X., Li, Y., Zheng, L., Zhou, Y., Jiang, H., Ning, T., Basang, Z., Zhang, C., & Ke, Y.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-08
- Volume
- 279
- Issue
- 34
- Pages
- 35664-35670
- ISSN
- 0021-9258
- Cited by
- 96
- References
- 4
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review